Keyphrases
Therapeutic Target
100%
Cutaneous T-cell Lymphoma
100%
Protein Kinase
40%
Cell Death
40%
Putative Drug Targets
40%
Small Molecule Inhibitors
40%
Patient Cells
40%
Glycogen Synthase Kinase 3 (GSK3)
40%
Mitogen-activated Protein Kinase
20%
Hematological Malignancies
20%
Clinically Significant
20%
Leukemia
20%
Disease Pathogenesis
20%
T Cell Receptor
20%
Lymphoma Cells
20%
Differentially Expressed
20%
Further Analysis
20%
Inhibitor Treatment
20%
Microarray Analysis
20%
New Therapeutic Modalities
20%
Synergistic Apoptosis
20%
Global Gene Expression
20%
Gene Set Enrichment Analysis
20%
T Cell Mitogen
20%
Combination Drug Treatment
20%
Immune Cell Signature
20%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Small Molecule
40%
Glycogen Synthase Kinase 3
40%
Cell Death
40%
Protein Kinase C
40%
Signal Transduction
20%
Candidate Gene
20%
T Cell Receptor
20%
Gene Expression
20%
Immunocompetent Cell
20%
Microarrays
20%
Mitogen-Activated Protein Kinase
20%
Gene Set Enrichment Analysis
20%
Immunology and Microbiology
T Cell
100%
Cell Line
50%
Cell Death
50%
Mitogen
25%
T Cell Receptor
25%
Gene Expression
25%
Immunocompetent Cell
25%
Cutaneous T-Cell Lymphoma Cell Line
25%
Signal Transduction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
Cutaneous T Cell Lymphoma
62%
Glycogen Synthase Kinase 3
25%
Protein Kinase C
25%
Pharmacotherapy
12%
Biological Marker
12%
Mitogen Activated Protein Kinase
12%
T Lymphocyte Receptor
12%
Hematopoietic System Malignancy
12%
Disease
12%
Combination Drug
12%